BUPROPION XL 300 mg AURO


EXTENDED RELEASE TABLETS
scheduling status
S5
registration number
56/1.2/0752
What BUPROPION XL 300 mg AURO contains
BUPROPION.
other ingredients
Inner core Microcrystalline cellulose USNF Hydrochloric acid USNF Sodium Stearyl Fumurate USNF Povidone USP Glyceryl Dibehenate USNF Stage I (Extended Release) Coating Ethyl cellulose USNF Povidone USP Polyethylene Glycol USNF Alcohol USP [Ethanol 96 % v/v] Stage II (Delayed Release) Coating Methacrylic acid and Ethyl Acrylate copolymer dispersion USNF Triethyl citrate USNF Polyethylene Glycol USNF Silicon Dioxide USNF (Syloid AL-1-FP) Stage III (Film) coating Opadry AMB white OY-B-28920 IH Final Coated Tablet weight (Stage III) Opacode Black S-1-17823 Isopropyl Alcohol USP.
Therapeutic classification
N06AX12.
BUPROPION XL 300 mg AURO
© 2026 SAHPRA. ALL RIGHTS RESERVED